Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine? - Wikidata - awgldk - TriplyDB

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

http://www.wikidata.org/entity/Q33895407

about

Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China.

P2860

Q40022563-997B529F-1EA6-4441-B8C1-16B6932F4A5F

P2860

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

http://www.wikidata.org/entity/Q33895407

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Does participation in a weight ...... renia treated with olanzapine?

@ast

Does participation in a weight ...... renia treated with olanzapine?

@en

type

label

Does participation in a weight ...... renia treated with olanzapine?

@ast

Does participation in a weight ...... renia treated with olanzapine?

@en

prefLabel

Does participation in a weight ...... renia treated with olanzapine?

@ast

Does participation in a weight ...... renia treated with olanzapine?

@en

P1433

Q33895407-D30485B4-28C9-44B1-9DDF-788161EB23F7

P1476

Q33895407-A4FB1415-F048-4C9D-9EA2-DDF08B912E76

P2093

Q33895407-1B1B7D83-8AF8-44F5-8C98-C162B601C974

Q33895407-3B62DED0-8A4B-4A27-804F-051BC71774C7

Q33895407-3C2A0BEE-1753-4EDD-958D-E8F3C154D72F

Q33895407-5868F13A-FFA2-45A4-B9DD-E2CFFA17E9C1

Q33895407-62B569AE-9EF6-4B08-A6E7-E2836B2FEB04

Q33895407-7B3BDBF2-B32F-4ABC-8244-90F7BA2DF070

Q33895407-B90B2942-AB35-44A5-9195-AFB05251CB45

Q33895407-BCA1128A-D350-4661-958C-19E0621A9A66

P2860

Q33895407-021DF3AC-283E-4238-A009-1CD120EF4798

Q33895407-05CB2EB2-5D0A-4317-B0C4-26F13C461C5B

Q33895407-06610503-24C6-48A1-AB26-24CDC1FC89F2

Q33895407-0737ABD6-99A7-4153-B322-8F3E5B94DD5D

Q33895407-08BD3CE2-A636-4A57-B7F1-549AACC45256

Q33895407-0C3F5D42-218D-4FEF-B53C-9FFCB0A41D77

Q33895407-0E6D9897-02D1-4671-BF3B-622B28919EFA

Q33895407-15CD7A3D-9CAB-4ED2-B585-72229269B277

Q33895407-26FE3795-535F-4B1D-B36F-892D36E2073D

Q33895407-3644D269-28DF-4C4A-ADB5-957BC3085873

P304

Q33895407-11A54422-5D89-448A-9CE3-5DD970151EB5

P31

Q33895407-FF1647B5-B138-4609-A42D-24F8EF0A4DDB

P356

Q33895407-BCA15575-2F36-4415-9652-936BA9A6348B

P407

Q33895407-FC8F5E01-8C18-4A85-BD80-D09E5180A8EF

P478

Q33895407-64AB0294-46A1-4325-9C74-373CF3A03251

P50

Q33895407-41F0DB92-3DE7-43E8-B4C8-9C9ABFA31259

P577

Q33895407-96E74CAB-6A1C-456C-AA99-C485A97EB25F

P698

Q33895407-087A5203-CBAE-4813-BB6C-1DDA2B64E6AF

P921

Q33895407-D2D90B38-469C-4E18-BC78-34559B7CC207

P932

Q33895407-D8A8AD9A-68B3-418E-9BD4-FA34C48ED128

P356

P1433

Neuropsychiatric Disease and Treatment

P1476

Does participation in a weight ...... renia treated with olanzapine?

@en

P2093

Hai Bo Xue

http://www.w3.org/2001/XMLSchema#string

Li Liu

http://www.w3.org/2001/XMLSchema#string

Michael D Stensland

http://www.w3.org/2001/XMLSchema#string

Sheng Hu Wu

http://www.w3.org/2001/XMLSchema#string

Tamas Treuer

http://www.w3.org/2001/XMLSchema#string

Wenyu Ye

http://www.w3.org/2001/XMLSchema#string

William Montgomery

http://www.w3.org/2001/XMLSchema#string

Zbigniew Kadziola

http://www.w3.org/2001/XMLSchema#string

P2860

Maintenance treatment with antipsychotic drugs for schizophrenia

Antipsychotic-induced weight gain: a comprehensive research synthesis

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.

The potential role of appetite in predicting weight changes during treatment with olanzapine.

Practice guideline for the treatment of patients with schizophrenia, second edition.

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials.

Weight change from 3-year observational data: findings from the worldwide schizophrenia outpatient health outcomes database.

P304

1287-1296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S60246

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Haya Ascher-Svanum

P577

2014-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25031537

http://www.w3.org/2001/XMLSchema#string

P921

P932

4096454

http://www.w3.org/2001/XMLSchema#string